Hyman SE. Back to basics: luring industry back into neuroscience. Nat Neurosci. 2016;19(11):1383-1384. doi:10.1038/nn.4429
Stanley Center for Psychiatric Research
Hyman SE, Landis SC, Leshner AI. Research Into Brain Disorders as an Example of Targeted Science. JAMA. 2016;316(16):1673-1674. doi:10.1001/jama.2016.12412
Andrade A, Hope J, Allen A, Yorgan V, Lipscombe D, Pan JQ. A rare schizophrenia risk variant of CACNA1I disrupts CaV3.3 channel activity. Sci Rep. 2016;6:34233. doi:10.1038/srep34233
Chen N, Sugihara H, Kim J, et al. Direct modulation of GFAP-expressing glia in the arcuate nucleus bi-directionally regulates feeding. Elife. 2016;5. doi:10.7554/eLife.18716
Manoach DS, Pan JQ, Purcell SM, Stickgold R. Reduced Sleep Spindles in Schizophrenia: A Treatable Endophenotype That Links Risk Genes to Impaired Cognition? Biol Psychiatry. 2016;80(8):599-608. doi:10.1016/j.biopsych.2015.10.003
Coleman JJ, Komura T, Munro J, et al. Activity of caffeic acid phenethyl ester in Caenorhabditis elegans. Future Med Chem. 2016. doi:10.4155/fmc-2016-0085
Wagner FF, Weïwer M, Steinbacher S, et al. Kinetic and structural insights into the binding of histone deacetylase 1 and 2 (HDAC1, 2) inhibitors. Bioorg Med Chem. 2016;24(18):4008-4015. doi:10.1016/j.bmc.2016.06.040
Bara AM, Messana A, Herring A, Hazelbaker DZ, Eggan K, Barrett LE. Generation of a TLE3 heterozygous knockout human embryonic stem cell line using CRISPR-Cas9. Stem Cell Res. 2016;17(2):441-443. doi:10.1016/j.scr.2016.09.008
Herring A, Messana A, Bara AM, Hazelbaker DZ, Eggan K, Barrett LE. Generation of a TLE1 homozygous knockout human embryonic stem cell line using CRISPR-Cas9. Stem Cell Res. 2016;17(2):430-432. doi:10.1016/j.scr.2016.09.009
Song J, Bergen SE, Di Florio A, et al. Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder. Mol Psychiatry. 2016;21(9):1290-7. doi:10.1038/mp.2015.165